ESR1 and breast carcinoma: Interestingly, an increase in ERα but a decrease in ERβ expression has been observed in human thyroid cancer cells (83, 84), which suggests that, as for breast cancer, an imbalance in the expression of the two isoforms may favor human thyroid cancer progression (76, 81).